Frontlight ResearchEarly access
Trial site
Texas Oncology Sammons Cancer Center
- 4running trials
- 6closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia2 trials
- Lung cancer2 trials
- Chronic lymphocytic leukaemia1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Liver and biliary tract cancer1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Myelodysplastic syndromes1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 24 trials
- Phase 33 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Terminated4 trials
- Recruiting3 trials
- Completed2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Celgene1 trial
- Curis, Inc.1 trial
- Mirati Therapeutics Inc.1 trial
- Novartis Pharmaceuticals1 trial
- NovoCure GmbH1 trial
- and 5 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic lymphocytic leukaemia1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Lung cancer1 recruiting
Closed trials
Completed
Terminated
Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer
Terminated
Completed
Terminated
Terminated
Site data: ClinicalTrials.govUpdated 18 Nov 2026